Novel gene C17orf37 in Prostate Cancer Progression and Metastasis: A Prospective Biomarker
Annual summary rept. 1 May 2009-30 Apr 2010
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER FORT WORTH TX
Pagination or Media Count:
The project focuses on novel gene named Chromosome 17 open reading frame 37 C17orf37 in prostate cancer progression and metastasis. Although the gene is overexpressed in different forms of cancer, its expression and role in prostate cancer is poorly understood. The Aims of the project are to 1 To establish the correlation of C17orf37 protein expression with poor pathological and prognostic variables in prostatic adenocarcinomas, and 2 To directly demonstrate the biological consequences of C17orf37 overexpression in promoting prostate tumor metastasis and elucidate the molecular mechanisms regulating the process in vivo. This is the first annual report, and we have identified that C17orf37 is overexpressed in prostate cancer patients compared to normal prostatic tissues. We also discovered that overexpression of C17orf37 potentiates migration and invasion of prostate cancer cells through AktNF-kB downstream target genes. We have also established the stable cell lines expressing C17orf37, and currently evaluating role of C17orf37 in prostate cancer metastasis.
- Medicine and Medical Research